Rong Guan is an Internal Medicine provider in Boston, Massachusetts. Dr. Guan is rated as an Advanced provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Heterozygous Familial Hypercholesterolemia (HeFH), Homozygous Familial Hypercholesterolemia (HoFH), Jaundice, and Hepatitis.

Jon Cronin is an Internal Medicine provider in Milton, Massachusetts. Dr. Cronin is rated as an Advanced provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Sitosterolemia, Atrial Fibrillation, Inappropriate Sinus Tachycardia (IST), and High Cholesterol.

Mark Benson is an Internal Medicine provider in Boston, Massachusetts. Dr. Benson is rated as an Advanced provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are High Cholesterol, Hyperlipoproteinemia Type 4, Homozygous Familial Hypercholesterolemia (HoFH), Angioplasty, and Heart Transplant.

Mallory Hatfield is an Internal Medicine provider in Hyannis, Massachusetts. Dr. Hatfield is rated as an Advanced provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). Her top areas of expertise are Hypertensive Heart Disease, Adenosine Deaminase 2 Deficiency, Pediatric Myocarditis, and Angina.

Matthew Kulke is an Oncologist in Boston, Massachusetts. Dr. Kulke is rated as an Experienced provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Carcinoid Syndrome, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), and Liver Embolization. Dr. Kulke is currently accepting new patients.

Andrew Fay is a primary care provider, practicing in Internal Medicine in South Hadley, Massachusetts. Dr. Fay is rated as an Experienced provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Maturity Onset Diabetes of the Young, Grass Allergy, Peripheral Artery Disease, and Sitosterolemia. Dr. Fay is currently accepting new patients.

Sekar Kathiresan is a primary care provider, practicing in Internal Medicine in Boston, Massachusetts. Dr. Kathiresan is rated as a Distinguished provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Coronary Heart Disease, High Cholesterol, Familial Hypercholesterolemia, and Atherosclerosis.

Ronen Durst is a Cardiologist in Boston,, Massachusetts. Dr. Durst is rated as an Advanced provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Mitral Valve Prolapse, High Cholesterol, Defective Apolipoprotein B-100, and Homozygous Familial Hypercholesterolemia (HoFH).

Sarah Deferranti is a Pediatric Cardiologist in Boston, Massachusetts. Dr. Deferranti is rated as an Advanced provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). Her top areas of expertise are Kawasaki Disease, Coronary Artery Fistula, Pulmonary Valves Agenesis, and Congenital Mitral Stenosis.

Paul Pettinato is a primary care provider, practicing in Internal Medicine in Needham, Massachusetts. Dr. Pettinato is rated as an Advanced provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Cirrhosis, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, and Sitosterolemia.

Dr. Jorge Plutzky is director of Preventive Cardiology at Brigham and Women’s Hospital (BWH). A cardiovascular medicine specialist, he is also an associate professor of medicine at Harvard Medical School.Dr. Plutzky received his medical degree from University of North Carolina at Chapel Hill School of Medicine. He completed a residency in internal medicine at BWH and West Roxbury Veterans Administration Medical Center (now VA Boston Healthcare Systems), as well as a fellowship in cardiology at BWH. Dr. Plutzky is board certified in internal medicine and cardiovascular disease.Dr. Plutzky’s clinical interests include cardiovascular disease, preventive education on cardiac disorders, and the impact of diabetes and bariatric conditions on cardiovascular health. The author of more than 50 peer-reviewed publications, his research interests include metabolic pathways, lipid metabolism, arteriosclerosis, thrombosis and vascular biology. Dr. Plutzky is rated as an Experienced provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are High Cholesterol, Heart Attack, Atherosclerosis, Cardiac Ablation, and Pacemaker Implantation.

Anne Rogal is a primary care provider, practicing in Internal Medicine in Milton, Massachusetts. Dr. Rogal is rated as an Experienced provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). Her top areas of expertise are Type 2 Diabetes (T2D), Hyperlipoproteinemia Type 4, Defective Apolipoprotein B-100, and Familial Hypercholesterolemia.

Dr. Peter Libby is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH) and the Mallinckrodt Professor of Medicine at Harvard Medical School (HMS).Dr. Libby received his medical degree from the University of California, San Diego School of Medicine. He completed a residency in internal medicine and a fellowship in cardiovascular disease at Peter Bent Brigham Hospital (now BWH). He also completed a research fellowship in cellular physiology at HMS. Dr. Libby is board certified in internal medicine and cardiovascular disease.The author of some 400 original peer-reviewed publications, some 450 reviews, chapters, or other publications, Dr. Libby also serves as an Editor of the leading textbook of cardiovascular medicine.  Dr. Libby's clinical and research interests include vascular biology, atherosclerosis and preventive cardiology. The research laboratory that Dr. Libby directs studies the messengers created by the body that may produce arterial plaque and blockages, as well as normal and abnormal function of smooth muscle and endothelial cells. Dr. Libby is perennially named a top cardiologist. His research has received funding from the American Heart Association and National Institutes of Health. Dr. Libby has received research recognitions on four continents including the highest research awards from the American Heart Association and American College of Cardiology, the Gold Medal of the European Society of Cardiology, the Anitschkow award from the European Atherosclerosis Society, The Ernst Jung Gold Medal for Medicine, and the Earl Benditt award for vascular biology. Dr. Libby is rated as an Experienced provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Abdominal Aortic Aneurysm (AAA), Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

Daniel Kirshenbaum is an Internal Medicine provider in Milton, Massachusetts. Dr. Kirshenbaum is rated as an Experienced provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Sitosterolemia, Fainting, Inappropriate Sinus Tachycardia (IST), and Familial Ventricular Tachycardia.

Patrick T. O'Gara, MD, is the Director of Strategic Planning for the Cardiovascular Division at Brigham and Women’s Hospital, the Watkins Family Distinguished Chair in Cardiology and Professor of Medicine at Harvard Medical School. His clinical activities are focused on patients with valvular heart disease, other structural heart diseases and aortic diseases, although he also maintains a large practice of general cardiology. Since 2001, he has been named annually among the Top Doctors in Boston and the U.S.O'Gara served as President of the American College of Cardiology (ACC) in 2014-15. Additional ACC leadership positions include his roles as Co-Chair of the ACC 2012 Scientific Session program committee, co-directorship of the ACC Board Review Course for Certification and Recertification, and Editor-in-Chief of the ACC Self-Assessment Program (ACCSAP). He served as Chair of the American Heart Association's (AHA's) Council on Clinical Cardiology from 2003-2005 and as the inaugural Editor of Heart Insight magazine from 2006 to 2011. In 2011, he received the Paul Dudley White Award from the Boston Division of the AHA Founder's Affiliate and has also been recognized with the Laennec Master Clinician Award (2011) and the Laennec Clinician Educator Award (2012). O'Gara was Chair of the writing committee for the 2013 ACC/AHA Guideline for the Management of Patients with ST-Elevation MI and has participated in several other guideline, expert consensus, scientific advisory and appropriate use criteria writing groups.He is currently the Vice-Chair for the AHA/ACC Task Force on Clinical Practice Guidelines. He is also the Steering Committee Co-Chair of the National Heart, Lung, and Blood Institute's Cardiothoracic Surgery Network, which has completed 3 groundbreaking, randomized controlled trials in cardiac surgery. O’Gara serves as Associate Editor for JAMA Cardiology and is a member of the Editorial Boards of the Journal of the American College of Cardiology and Circulation. He has lectured widely and authored or co-authored over 250 original manuscripts, chapters, critical reviews, statements and editorials. Dr. O'gara is rated as an Experienced provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Aortic Valve Stenosis, Mitral Valve Regurgitation, Bicuspid Aortic Valve, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Mario Motta is a Cardiologist in Salem, Massachusetts. Dr. Motta is rated as an Experienced provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Atrial Fibrillation, Arrhythmias, Familial Progressive Cardiac Conduction Defect, Heart Attack, and Pacemaker Implantation.

Timothy Fitzgibbons is a Cardiologist in Worcester, Massachusetts. Dr. Fitzgibbons is rated as an Experienced provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Atrial Fibrillation, Catecholaminergic Polymorphic Ventricular Tachycardia, Ventricular Tachycardia, Cardiac Ablation, and Pacemaker Implantation.

Junyang Lou is a Cardiologist in Boston, Massachusetts. Dr. Lou is rated as an Experienced provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, Angioplasty, and Aortic Valve Replacement.

Robert Giugliano is a Cardiologist in Boston,, Massachusetts. Dr. Giugliano is rated as an Experienced provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Atrial Fibrillation, Acute Coronary Syndrome, Heart Attack, Percutaneous Coronary Intervention (PCI), and Coronary Artery Bypass Graft (CABG).

Vikram Grewal is a Cardiologist in Northampton, Massachusetts. Dr. Grewal is rated as an Experienced provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Atrial Fibrillation, Spontaneous Coronary Artery Dissection (SCAD), Inappropriate Sinus Tachycardia (IST), and Familial Ventricular Tachycardia.